Speak to us about what you need and we'll take into account your budget and requirements. This gives you the choice and flexibility to achieve the service you're looking for.

The best time to seek advice will vary for different technologies. Typically we provide advice before phase 3 trials begin.

If your technology is in the later stages of development, please contact us to discuss your requirements.

Our advice services

Scientific advice

Get detailed advice - both clinical and economic - from NICE and a panel of experts. Talk to us about the options available for small and medium-sized enterprises. 

Express scientific advice

An accelerated version of our standard scientific advice service, to suit a more immediate need in a shorter timeframe.

Parallel and joint advice services

European early dialogues

Health Technology Assessment (HTA) and regulatory advice from NICE, the European Medicines Agency (EMA) and selected European HTA bodies.

NICE-MHRA scientific advice

Joint Health Technology Assessment and regulatory advice from NICE and the Medicines and Healthcare products Regulatory Agency.

European health technology assessment and regulatory concurrent advice

A service designed to provide scientific advice from NICE within similar timelines to the EMA scientific advice process.